These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25346917)

  • 1. Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty.
    Lee JW; Kim HJ; Choe YM; Kang HS; Kim SK; Jun YH; Lee JE
    Ann Pediatr Endocrinol Metab; 2014 Sep; 19(3):135-40. PubMed ID: 25346917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Hypersensitivity Reactions with Leuprolide Acetate and Triptorelin Acetate in Children.
    Metbulut AP; Adıgüzel KT; İslamoğlu C; Boyraz M; Mısırlıoğlu ED
    Indian J Endocrinol Metab; 2021; 25(6):527-531. PubMed ID: 35355908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of slipped capital femoral epiphysis in children undergoing gonadotropin-releasing hormone agonist therapy for the treatment of central precocious puberty.
    Inman M; Hursh BE; Mokashi A; Pinto T; Metzger DL; Cummings EA
    Horm Res Paediatr; 2013; 80(1):64-8. PubMed ID: 23859950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leuprolide and triptorelin treatment in children with idiopathic central precocious puberty: an efficacy/tolerability comparison study.
    Valenzise M; Nasso C; Scarfone A; Rottura M; Cafarella G; Pallio G; Visalli G; Di Prima E; Nasso E; Squadrito V; Wasniewska M; Irrera P; Arcoraci V; Squadrito F
    Front Pediatr; 2023; 11():1170025. PubMed ID: 37266535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
    Clemons RD; Kappy MS; Stuart TE; Perelman AH; Hoekstra FT
    Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects and significant Adverse Drug Reactions (ADRs) associated with the use of Gonadotropin-Releasing Hormone analogs (GnRHa) for central precocious puberty: a brief review of literature.
    De Sanctis V; Soliman AT; Di Maio S; Soliman N; Elsedfy H
    Acta Biomed; 2019 Sep; 90(3):345-359. PubMed ID: 31580327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty.
    Kim EY
    Korean J Pediatr; 2015 Jan; 58(1):1-7. PubMed ID: 25729392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty.
    Lee HS; Yoon JS; Roh JK; Hwang JS
    Endocrine; 2016 Nov; 54(2):497-503. PubMed ID: 27444748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid outcome during long-term gonadotropin-releasing hormone agonist treatments for idiopathic precocious puberty.
    Massart F; Harrell JC; Federico G; Saggese G
    J Adolesc Health; 2007 Mar; 40(3):252-7. PubMed ID: 17321426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of a triptorelin 3-month depot in girls with central precocious puberty.
    Park KH; Gwag SH; Kim YJ; Chung LY; Kang E; Nam HK; Rhie YJ; Lee KH
    Ann Pediatr Endocrinol Metab; 2024 Jun; 29(3):161-166. PubMed ID: 38291760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central precocious puberty: revisiting the diagnosis and therapeutic management.
    Brito VN; Spinola-Castro AM; Kochi C; Kopacek C; Silva PC; Guerra-Júnior G
    Arch Endocrinol Metab; 2016 Apr; 60(2):163-72. PubMed ID: 27191050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histrelin implant: a novel treatment for central precocious puberty.
    Hirsch HJ; Gillis D; Strich D; Chertin B; Farkas A; Lindenberg T; Gelber H; Spitz IM
    Pediatrics; 2005 Dec; 116(6):e798-802. PubMed ID: 16322137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in body mass index in children on gonadotropin-releasing hormone agonist therapy with precocious puberty, early puberty or short stature.
    Censani M; Feuer A; Orton S; Askin G; Vogiatzi M
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1065-1070. PubMed ID: 31465296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
    Massart F; Federico G; Harrell JC; Saggese G
    Neuroendocrinology; 2009; 90(3):307-14. PubMed ID: 19641297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls.
    Shiasi Arani K; Heidari F
    Int J Endocrinol Metab; 2015 Jul; 13(3):e23085. PubMed ID: 26401141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward More Targeted and Cost-Effective Gonadotropin-Releasing Hormone Analog Treatment in Girls with Central Precocious Puberty.
    Kaplowitz PB; Backeljauw PF; Allen DB
    Horm Res Paediatr; 2018; 90(1):1-7. PubMed ID: 30048994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in body mass index in boys with central precocious puberty over 2 years of gonadotropin-releasing hormone agonist therapy.
    Lim KI; Lee HS; Hwang JS
    Ann Pediatr Endocrinol Metab; 2020 Sep; 25(3):169-173. PubMed ID: 33017886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty.
    Lee HS; Yoon JS; Park KJ; Hwang JS
    PLoS One; 2018; 13(8):e0201906. PubMed ID: 30133462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin secretion before, during, and after chronic gonadotropin-releasing hormone agonist treatments in children.
    Massart F; Parrino R; Placidi G; Massai G; Federico G; Saggese G
    Fertil Steril; 2005 Sep; 84(3):719-24. PubMed ID: 16169408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.